Resources for News Media
The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.
For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.
Connect with Us
Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.
Email: ncipressofficers@mail.nih.gov
Phone: 240-760-6600
Social Media:
@NCIMedia
NCI's YouTube Channel
Address:
Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580
Recent Interviews from Scientists at NCI
-
Drug Approved to Help Young Patients Battle a Rare Cancer
January 2, 2023 | HealthDay
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) for use in patients with advanced alveolar soft part sarcoma (ASPS) that has spread to other parts of the body or cannot be removed by surgery. -
A new kind of blood test can screen for many cancers — as some pregnant people learn
December 23, 2022 | NPR
The simple blood test looks at DNA that's floating freely in a pregnant person's bloodstream. It searches for bits released by cells in the placenta, which should have the same genetic make-up as the fetus. -
Few Americans aware of cancer risks posed by alcohol: study
December 2, 2022 | The Hill
A low number of Americans are aware of the myriad cancer risks posed by alcohol consumption. Just over 30 percent know liquor can increase the risk of certain cancers, while 25 percent said the same about beer and 20 percent about wine, according to a new study from the American Association of Cancer Research (AACR). -
Dogs may hold key to treating cancer in humans
November 27, 2022 | CBS News
Some 4 million dogs in the U.S. are diagnosed with cancer every year, often the same kinds humans get. And since we share many of the same genes with our canine companions, dogs with naturally developing cancers are being enrolled in clinical trials, with doctors and scientists using what they learn to speed potential treatments to them and us. It's called comparative oncology and it's now funded in part by the White House's Cancer Moonshot Initiative. -
US cancer death rates across all age groups continue on downward trend, new study shows
October 27, 2022 | USA Today
Overall U.S. cancer death rates continue to drop among men, women, children, teens and young adults, according to a report released Thursday. -
Monica Bertagnolli: “We must be willing to admit where our efforts have fallen short and be open to new ideas”
October 7, 2022 | The Cancer Letter
Bertagnolli is the first woman and the first chair of a clinical trials cooperative group to hold the position of NCI director. Her appointment was announced by President Biden nearly two months ago. Bertagnolli succeeds Norman E. Sharpless, who stepped down as director in April 2022 -
Telehealth For Cancer Care Receives $23 Million Research Funding Boost
August 18, 2022 | Forbes
The National Cancer Institute at the National Institutes of Health (NIH) will award funding to conduct research into the use of telehealth for cancer care by creating four new “Telehealth Research Centers of Excellence.” -
Drinking Black Tea May Lower Mortality Risk, Study Suggests
August 29, 2022 | Time
While green tea has a long-standing reputation for health benefits, research has been much more mixed on black tea. One problem, says Maki Inoue-Choi, an epidemiologist at the National Cancer Institute, is that large observational studies on tea and mortality have focused on countries like Japan or China—places where green tea is more popular. -
The Cancer Grand Challenges Program Awards $100 Million To Four Research Teams
June 16, 2022 | Forbes
The National Cancer Institute (NCI), part of the National Institutes of Health, announced on Thursday that four international research teams had been selected to receive a total of $100 million as part of the Cancer Grand Challenges program. Each team will receive $25 million over five years as it tackles one of cancer’s most challenging problems. -
Screening and Early Treatment Reduce Anal Cancer in People With HIV
June 17, 2022 | POZ
Screening people with HIV for precancerous anal cell changes and treating them promptly lowered the risk of progression to anal cancer by more than half, according to results from the ANCHOR study published this week in the New England Journal of Medicine. -
'We still are dying at alarming rates': Black cancer death rates are falling but remain higher than others, study finds
May 19, 2022 | USA Today
Despite declining cancer death rates, Black people still died of cancer at higher rates than any other racial group, a new study shows.
Trending Topics
-
NCI Director Dr. Monica M. Bertagnolli
Learn about Monica M. Bertagnolli, M.D., and NCI Director. She is a physician–scientist and surgeon whose research interests include gastrointestinal cancer development and the role of inflammation as a driver of cancer growth.
-
Breast Cancer—Patient Version
Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread. Start here to find information on breast cancer treatment, causes and prevention, screening, research, and statistics.
-
Uterine Cancer—Patient Version
Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.
-
White House Fact Sheet: President Biden Details Cancer Moonshot Progress and New Initiatives on 60th Anniversary of President Kennedy’s Moonshot Address
Sixty years ago today, President John F. Kennedy delivered his Moonshot speech at Rice University, committing to putting a man on the moon and bring him back. This afternoon at the John F. Kennedy Presidential Library and Museum in Boston, President Biden will discuss his bold vision for another American moonshot: ending cancer as we know it. It is a vision that will change people’s lives for the better, improve their health, and decrease the burden of the disease.
-
Cancer Treatment Vaccines
Cancer treatment vaccines treat cancer by strengthening the body’s natural defenses against the cancer. This page covers how cancer treatment vaccines work against cancer, cancers that are treated with them, and the side effects they may cause.
-
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
From 1999—2019, US rates of cancer death fell among Black people. Yet, in 2019, their rates remained higher than those of other racial and ethnic groups.
-
NCI COVID-19 in Cancer Patients Study (NCCAPS)
The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.
Multimedia from NCI
50 Years of Cancer Treatment and Diagnostics
Clinical trials, innovation in research, and technology have improved cancer treatment and diagnostics in public health. Listen to Healthcast’s National Cancer Act podcast series to learn more.
Recent News Releases
-
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
-
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
-
Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.